Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients
Now that Wegovy and Ozempic supplies are classified as stable, this loophole closes
In May 2022, Tirzepatide was approved for marketing by the FDA for the treatment of type 2 diabetes in adults
From there, you can optionally enable Apple Health sync, customize which metrics (weight, protein, calories, water, side effects) you want to track, and start viewing your progress charts
For tirzepatide (Zepbound) Jastreboff and colleagues reported in the New England Journal of Medicine in 2022 that at maximal doses, the percent of individuals reporting side effects were as follows: Nausea 31.0% Diarrhea 23.0% Vomiting 12.2% Constipation 11.7% Bettge and colleagues conducted a study published in Diabetes, Obesity, and Metabolism in 2017 that showed that individuals who were taking metformin while taking a GLP-1 were more likely to have side effects, especially nausea and vomiting
A: We prioritize quality and transparency